ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Okta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OKTA

NEW YORK, May 29, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Okta, Inc. (NASDAQ: OKTA) between March 5, 2021 and March 22, 2022, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than July 19, 2022.

SO WHAT: If you purchased Okta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Okta class action, go to https://rosenlegal.com/submit–form/?case_id=6365 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 19, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Okta had inadequate cybersecurity controls; (2) as a result, Okta's systems were vulnerable to data breaches; (3) Okta ultimately did experience a data breach caused by a hacking group, which potentially affected hundreds of Okta customers; (4) Okta initially did not disclose and subsequently downplayed the severity of the data breach; (5) all the foregoing, once revealed, was likely to have a material negative impact on Okta's business, financial condition, and reputation; and (6) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Okta class action, go to https://rosenlegal.com/submit–form/?case_id=6365 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8561613)

ROSEN, A LEADING LAW FIRM, Encourages Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ARQQ, ARQQW, CENH, CENHU, CENHW

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. (NASDAQ: ARQQ, ARQQW, CENH, CENHU, CENHW): (i) between September 7, 2021 and April 18, 2022, both dates inclusive (the "Class Period"); and/or (ii) all holders of Centricus securities as of the record date for the special meeting of shareholders held on August 31, 2021 to consider approval of the merger between Arqit and Centricus (the "Merger") and entitled to vote on the Merger, of the important July 5, 2022 lead plaintiff deadline in the securities class action commenced by the Firm.

SO WHAT: If you purchased Arqit securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Arqit class action, go to https://rosenlegal.com/submit–form/?case_id=5481 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 5, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period and in the Proxy Statement issued in connection to the Merger made false and/or misleading statements and/or failed to disclose: (1) Arqit's proposed encryption technology would require widespread adoption of new protocols and standards of for telecommunications; (2) British cybersecurity officials questioned the viability of Arqit's proposed encryption technology in a meeting in 2020; (3) the British government was not an Arqit customer but, rather, providing grants to Arqit; (4) Arqit had little more than an early–stage prototype of its encryption system at the time of the Merger; and (5) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Arqit class action, go to https://rosenlegal.com/submit–form/?case_id=5481 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8561537)

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages IronNet, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – IRNT

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of IronNet, Inc. (NYSE: IRNT) between September 15, 2021 and December 15, 2021, inclusive (the "Class Period"), of the important June 21, 2022 lead plaintiff deadline.

SO WHAT: If you purchased IronNet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the IronNet class action, go to https://rosenlegal.com/submit–form/?case_id=5641 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 21, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) IronNet had materially overstated its business and financial prospects; (2) IronNet was unable to predict the timing of significant customer opportunities which constituted a substantial portion of its publicly–issued FY 2022 financial guidance; (3) IronNet had not established effective disclosure controls and procedures to reasonably ensure its public disclosures were timely, accurate, complete, and not otherwise misleading; and (4) as a result, defendants' public statements were materially false, misleading, and/or lacked any reasonable basis in fact at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the IronNet class action, go to https://rosenlegal.com/submit–form/?case_id=5641 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8561576)

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages HUMBL, LLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – HMBL

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of HUMBL, LLC (OTC: HMBL) and/or the Company's unregistered digital asset (sold as BLOCKS Exchange Traded Index ("ETXs") on various cryptocurrency exchanges) between November 1, 2020 and May 19, 2022, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than July 19, 2022.

SO WHAT: If you purchased Humbl securities and/or the Company's ETXs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Humbl class action, go to https://rosenlegal.com/submit–form/?case_id=6398 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 19, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants violated provisions of the Exchange Act by making false and misleading statements concerning the Company's growth prospects, technological advancements, international partnerships, and financial benefits for Humbl common stock and digital asset investors, as well as using selectively timed announcements to keep Humbl stock price high so that Company insiders could sell off their holdings into artificially created volume. The complaint also alleges that defendants violated provisions of the Securities Act by selling its unregistered securities (BLOCK ETX digital assets) to investors.

To join the Humbl class action, go to https://rosenlegal.com/submit–form/?case_id=6398 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8561572)

ABBV SHAREHOLDER ALERT: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action – ABBV

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and August 31, 2021, inclusive (the "Class Period"), of the important June 6, 2022 lead plaintiff deadline.

SO WHAT: If you purchased AbbVie securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the AbbVie class action, go to https://rosenlegal.com/submit–form/?case_id=5119 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 6, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) safety concerns about Xeljanz and Xeljanz XR extended to Rinvoq and other Janus kinase (JAK) inhibitors; (2) as a result, it was likely that the FDA would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, defendants' statements about AbbVie's business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the AbbVie class action, go to https://rosenlegal.com/submit–form/?case_id=5119 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8561533)

EVBG FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Everbridge, Inc. Investors With Losses to Secure Counsel Before Important June 3 Deadline in Securities Class Action – EVBG

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Everbridge, Inc. (NASDAQ: EVBG) between November 4, 2019 and February 24, 2022, inclusive (the "Class Period") of the important June 3, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Everbridge securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Everbridge class action, go to https://rosenlegal.com/submit–form/?case_id=3095 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 3, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Everbridge was experiencing integration problems with respect to its acquiring nine separate companies; (2) Everbridge was using the revenues from these acquisitions to mask increasingly stagnant organic growth; and (3) Everbridge was failing to disclose that the COVID–19 pandemic was having a material impact on the size of the deals that Everbridge was able to obtain, with a negative effect on the Company's revenue growth. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Everbridge class action, go to https://rosenlegal.com/submit–form/?case_id=3095 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8561488)

Dante Labs highlights advancements to its drug discovery development program, demonstrating the value of genomic data to drug discovery

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) — Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made in its drug discovery development program with six drug candidates currently in the Company's pipeline, applying Dante's internal siRNA and mRNA technology to rare and common diseases.

Since the company's foundation, Dante has invested in a robust R&D program with the goal to create end–to–end solutions from diagnosis to therapy. Dante's program began with a focus on rare disease, in response to a diagnosis of a patient with a rare disease for which there were no treatment therapies. Dante's pipeline has evolved across multiple disease areas with four drug programs in full internal development and two in co–development to achieve validation and partner externally on clinical trials and commercialization.

"Personalized medicine needs personalized data, and our progress in the last 18 months alone demonstrates the value of genomic data to research and discovery drug development," said Andrea Riposati, CEO of Dante Genomics. "When we founded Dante Genomics, we felt we had a responsibility to deliver personalized medicine beyond diagnosis so that no patient would be facing a diagnosis with no effective treatments. It is this holistic approach that challenges and motivates us as a company to accelerate science to save more lives."

Dante has advanced its internal drug programs in muscle rare disease and neurological rare disease into the pre–clinical phase. The newest addition to Dante's discovery program pipeline is an mRNA oncology therapeutic in the molecular discovery phase meant to strengthen the immune system against certain cancer types. In co–development with US biotechnology company Protelica, Dante has therapies in respiratory disease and ovarian cancer, both in the non–regulatory pre–clinical phase.

Dante's mRNA COVID vaccine program development began in early 2021 and has recently completed the regulatory pre–clinical phase and is ready for its first in–human.

"My academic background has taught me the value of RNA therapeutics, and Dante's internal R&D leverages mRNA and siRNA technology to accelerate time to patients from concept to clinic," said Mattia Capulli, Chief Scientific Officer of Dante Genomics. "The data and advanced timeline of our mRNA vaccine program demonstrates Dante's high quality RNA platform and the reproducibility of this model applied to other clinical therapies.

The Company also announced its rebrand to Dante Genomics to better reflect its global efforts in genomic information and personalized medicine. The company name, Dante Genomics, comes from the compound of humanity and science. "Dante" refers to the Italian humanitarian poet and "Genomics" refers to the powerful science that takes place in a genomics lab. Since its foundation, Dante Genomics has delivered hundreds of thousands of people with affordable, quality genomic solutions to inform their healthcare decisions. The Company's holistic approach to medicine spans from sequencing and variant interpretation to discovery drug development.

About Dante Genomics

Dante Genomics is a global genomic information company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. The Company uses its platform to deliver better patient outcomes from diagnostics to therapeutics with assets including one of the largest private genome databases with research consent, proprietary software designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Contact:

Laura D'Angelo
VP of Investor Relations
ir@dantelabs.com
+39 0862 191 0671
www.dantegenomics.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e163117–b6e3–40cc–8ecc–48cd9d72e8ce


GLOBENEWSWIRE (Distribution ID 8560383)

Preql raises $7M to build the future of data transformation

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) — Preql, a no–code data transformation solution, announced that it has raised $7 million in seed funding, led by Bessemer Venture Partners with participation from Felicis, and top founders in the analytics ecosystem including Taylor Brown from Fivetran, Keenan Rice from Looker, Tristan Handy from Dbt Labs, Eldad Fakash from Firebolt, and Benn Stancil from Mode. Preql's platform allows business users to structure data for reporting without having to write SQL or rely on specialized data talent.

Preql builds upon the innovation of tools like Snowflake and Fivetran, which have made aspects of the analytics workflow accessible to organizations without data engineering resources. The next evolutionary step in the modern data stack is to allow business users to manage their own logic for reporting "" something that's not possible today without advanced SQL and data transformation expertise.

Preql's Co–Founders and Co–CEOs, Gabi Steele and Leah Weiss, met while leading data teams at WeWork and went on to found a successful data engineering and visualization consultancy. During their time at WeWork, they experienced a disconnect between business users who need data for decision making and the data teams who structure and prepare data for analysis. Business users have to pass along definitions to data modeling specialists, who maintain logic in code but lack sufficient business context. Even with exceptional data talent, the result of this handoff is often lack of trust in data, frustrated data teams, and costly data investments without a clear path to ROI.

Preql's funding comes at a moment where companies of all sizes are now investing in data cloud data storage and ingestion tools. The cloud storage market is growing 22.3% each year. Despite these investments in modern infrastructure, few companies have the internal resources required to shape their data for analysis. "There's a misconception that simply storing data will help your organization become data driven. Data storage is necessary, but the hard part is agreeing on what you want to measure, how you want to measure it, and then translating that business logic into code," said Leah Weiss, Co–Founder. "Preql gives business users the ability to contextualize their data and customize definitions, but then abstracts away the complex work of data transformation."

Preql's technology sits on top of the data warehouse, predicts the data model required for your business, and then lets business users customize metric definitions. It compiles all of that logic and delivers reporting ready datasets back in your warehouse, something that previously took months of manual effort from highly skilled data teams. "We've seen first hand the pain business users and data teams experience while building out a central source of truth for reporting," said Gabi Steele, Co–Founder. "We are deeply committed to delivering a design forward and intuitive solution that business users will love and understand, and that more mature data teams are grateful for because it saves them so much back and forth."

"We're excited to partner with Preql to make data capabilities more accessible to organizations and verticals that are currently underserved," said Amit Karp, Partner at Bessemer Venture Partners. "We were really impressed with the unique insight the founders bring to this problem and the clarity of their vision." Viviana Faga, General Partner at Felicis adds, "we couldn't be more thrilled to partner with Gabi and Leah, who are on a mission to change the way data is transformed and accessed, better serving the needs of business users at every company."

About Preql
Preql is building automated data transformation for business users. Its technology empowers business users to access analysis–ready data in minutes without having to learn SQL or rely on a data team. Preql is backed by Bessemer Venture Partners, Felicis, and several angel investors. Learn more at preql.com.

About Bessemer Venture Partners
Bessemer Venture Partners helps entrepreneurs lay strong foundations to build and forge long standing companies. With more than 135 IPOs and 200 portfolio companies in the enterprise, consumer and healthcare spaces, Bessemer supports founders and CEOs from their early days through every stage of growth. Bessemer's global portfolio includes Pinterest, Shopify, Twilio, Yelp, LinkedIn, PagerDuty, DocuSign, Wix, Fiverr and Toast and has $9 billion of capital under management. Bessemer has teams of investors and partners located in Tel Aviv, Silicon Valley, San Francisco, New York, London, Boston, Beijing and Bangalore. Born from innovations in steel more than a century ago, Bessemer's storied history has afforded its partners the opportunity to celebrate and scrutinize its best investment decisions (see Memos) and also learn from its mistakes (see Anti–Portfolio).

About Felicis
Founded in 2006, Felicis is a venture capital firm investing in companies reinventing core markets, as well as those creating frontier technologies. Felicis focuses on early stage investments and currently manages over $2.1B in capital across 8 funds. The firm is an early backer of more than 41 companies valued at $1B+. More than 91 of its portfolio companies have been acquired or gone public, including Adyen (IPO), Credit Karma (acq by Intuit), Cruise (acq by General Motors), Fitbit (IPO), Guardant Health (IPO), Meraki (acq by Cisco), Ring (acq by Amazon), and Shopify (IPO). The firm is based in Menlo Park, CA. Learn more at www.felicis.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/98753d0b–a231–4884–a213–3f20c212a9bf


GLOBENEWSWIRE (Distribution ID 8560456)

TigerGraph’s Graph for All Million Dollar Challenge Winners Impress With Innovative Solutions to Global Issues Using Graph Technology

REDWOOD CITY, Calif., May 25, 2022 (GLOBE NEWSWIRE) — TigerGraph, provider of a leading graph analytics platform, today unveiled the winners of the Graph for All Million Dollar Challenge "" awarding $1 million in cash to game–changing, graph–powered projects that analyze and address many of today's biggest global social, economic, health, and climate–related concerns. The winning projects, announced at this week's Graph + AI Summit, were hand–selected by the global judging committee from more than 1,500 registrations from 100+ countries. Mental Health Hero claimed the $250k Grand Prize for creating an application to help provide greater access and personalization to mental health treatment.

"From addressing mental health issues to supporting Ukrainian refugees to predicting how supply shocks will spread through the world economy, the submissions we received tackle real–world concerns and demonstrate innovative approaches to resolving them with graph technology," said Dr. Yu Xu, founder and CEO of TigerGraph. "We wanted to create a challenge that produced new and innovative applications of graph technology and the global community did just that. The overwhelming focus on global issues in this challenge shows that regardless of geography, we all share many of the same concerns and challenges, and that graph technology can help address them."

Graph For All Million Dollar Challenge Winners
After extensive review by the global judging committee, consisting of 32 experts from industry, academia, and TigerGraph, the following are the 15 award–winning projects.

Graph For All Million Dollar Challenge Grand Prize Winner
Grand Prize, $250,000: Mental Health Hero – Mental Health Hero is a graph–based approach to solving one of the largest public health epidemics today: the prevalence of untreated mental health issues such as anxiety and depression. According to the CDC, 400 million people globally are not receiving essential treatment for their mental health disorders [1]. Additionally, only 40% of adults with mental illness are estimated to receive treatment for it [2].

Graph For All Million Dollar Challenge Top Awards
Most Impactful 1st place, $100,000: UAWelcome – The global refugee crisis reached a new level of awareness with the war in Ukraine. In response, UAWelcome created a platform that uses graph technology to connect individual refugees and their needs with a fast–growing community of volunteers and the limited and scattered resources. Their application is already in use connecting volunteers and scattered resources with Ukrainian refugees and helping refugees seek asylum in the U.S.

Most Innovative 1st place, $100,000: Universe Planner – A multiverse–metaverse planning app that allows users to solve complex problems by tapping into and leveraging social knowledge. It also socially connects users to others working on the same or similar mission, plan, or task.

Most Ambitious 1st place, $100,000: ShockNet – Allows users to adjust assumptions, investigate the predicted chains of shocks through the world economy, and identify ways to avoid economic crises by gaining visibility into how and why shocks spread. ShockNet includes an app that allows policymakers to visualize and adjust the model to better understand how to offset or avoid a future crisis.

Most Applicable 1st place, $100,000: BioDex – BioDex combines our natural curiosity with the motivation of gaming. By gamifying the experience of connecting to nature, players can snap images of nature, identify its species, and display its properties in real time while striving to identify as many species as possible and contributing biodiversity information to research.

Women Who Graph, $30,000: Diagnosx – After seeing first hand in the ER the dual struggles of patients not understanding their health conditions and doctors trying to draw pictures to help explain conditions, Bree Day knew there had to be a better way. Her idea to get 3D models to illustrate breadth and depth of a patient's diagnosis into all patients' hands is realized in Diagnosx. The application presents a 3D model of a patient's diagnosis and medical history to better illustrate the findings and diagnosis, and decrease disparities in doctor/patient communication.

Most Popular, $20,000: Multimodality Cancer Graph – Many diseases are related to each other, and complications from a certain disease could cause another. Through the power of graphs and machine learning, this project aims to uncover new disease links and help researchers better prepare for future pandemics or emerging diseases.

Additional Winners
Most Impactful

  • 2nd place, $50,000: Fact–Checker: Fighting Misinformation at Scale – A multi–platform, multi–lingual, real–time fact–checking system powered by machine learning and graph technology.
  • 3rd place, $25,000: Project Athena – An automatic, generic knowledge graph framework that builds itself from textual unstructured data and uses natural language to query and apply data.

Most Innovative

  • 2nd place, $50,000: RepoLinks – A graph that shows the dense, complex interconnections between software developers, programming languages, and software projects, to better understand factors such as skill sets, productivity, and technology evolution within organizations.
  • 3rd place, $25,000: Gemini – An eclectic news search engine that cuts through the noise and allows readers to dig deep into a specific topic or explore multiple facets of the news they are most interested in.

Most Ambitious

  • 2nd place, $50,000: Finding Drug Interactions in Silico with Graph – Identifies drug interactions and potential side effects using graph machine learning during the pharmaceutical development process.
  • 3rd place, $25,000: Candoor – A social networking site for people seeking to connect with others for candid conversations on anything from professional industry advice to tips for pursuing a hobby.

Most Applicable

  • 2nd place, $50,000: TigerGraph for United Nations (UN) Data – Makes UN data, the most robust dataset in the world, easily accessible to anyone by harnessing the power of graph technology.
  • 3rd place, $25,000: BiasCheck – A cool new Google Chrome extension that fosters critical thinking by identifying bias/accuracy of all news sources. The technology also allows users to explore specific topics with differing viewpoints that challenge the status quo.

The Graph for All Million Dollar Challenge judging committee was comprised of the world's brightest and most recognizable data scientists, professors, PhDs, distinguished engineers, and founders of global companies focusing on artificial intelligence (AI), analytics, knowledge graph, and other industry experts with deep knowledge of graph technology, graph use cases, and graph deployments. The judging committee included eight PhDs, three academics from top universities, an NSF Graduate Research Fellow, a marine geoscientist, and a 2x Kaggle Grand Master. TigerGraph engineers and product experts also joined the panel as employee judges.

"Wow! The creative use of graph and data in these solutions really shows how a graph approach with the right data can address so many global issues," said Juan Sequeda, principal scientist, data.world and Graph for All Million Dollar Challenge judge. "What is truly exciting is that most of these projects can be expanded and applied in many different situations and use cases in the future. The projects serve as templates that can be adjusted, augmented, and adapted for other situations, helping make life better for even more people. Like the project created to help Ukrainian refugees, while it is excellent for refugee situations, that same application could be used to help people impacted by natural disasters throughout the world."

Helpful Links

About TigerGraph
TigerGraph is a platform for advanced analytics and machine learning on connected data. Based on the industry's first and only distributed native graph database, TigerGraph's proven technology supports advanced analytics and machine learning applications such as fraud detection, anti–money laundering (AML), entity resolution, customer 360, recommendations, knowledge graph, cybersecurity, supply chain, IoT, and network analysis. The company is headquartered in Redwood City, California, USA. Start free with tigergraph.com/cloud.

Media Contacts:

North America
Tanya Carlsson
Offleash PR
tanya@offleashpr.com
+1 (707) 529–6139

EMEA
Anne Harding
The Message Machine
anne@themessagemachine.com
+44 7887 682943

APAC
Rasheed Abu Bakar
Sandpiper
rasheed.abubakar@sandpipercomms.com
+65 9112 6504


1 References
[1] https://futuresrecoveryhealthcare.com/blog/barriers–to–mental–health–treatment/
[2] https://towardsdatascience.com/data–science–in–mental–health–ccd09ba2148a


GLOBENEWSWIRE (Distribution ID 8559154)